Navigation Links
For the Treatment of Rheumatoid Arthritis, Market Share for TNF-alpha Inhibitors Will Decrease Through 2018
Date:5/18/2009

Actemra/RoActemra Will Emerge as the Preferred Biological Drug for TNF-Refractory Patients, According to a New Report from Decision Resources

WALTHAM, Mass., May 18 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, in the treatment of rheumatoid arthritis, the market share for TNF-alpha inhibitors will decrease to 63 percent through 2018 as a result of the increasing use of alternative agents to treat the disease. In 2008, TNF-alpha inhibitors such as Amgen/Wyeth/Takeda's Enbrel and Abbott/Eisai's Humira accounted for 80 percent of rheumatoid arthritis drug sales in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Rheumatoid Arthritis finds that alternative biologics such as Roche/Chugai's Actemra/RoActemra will take market share away from the TNF-alpha inhibitors as interviewed rheumatologists indicate they switch to one of these agents for patients who respond inadequately to two TNF-alpha inhibitors. Actemra/RoActemra will likely emerge as the preferred agent for TNF-refractory patients and is forecasted to achieve sales of nearly $2 billion in 2018.

The report also finds that Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe/Janssen's Simponi has advantages in its drug delivery and efficacy and is expected to take significant market share away from Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade. Simponi will also experience greater uptake than UCB/Otsuka's Cimzia, which has launched for the indication following its recent approval for rheumatoid arthritis by the Food and Drug Administration. Additionally, an emerging agent from Pfizer is expected to impact overall sales of biologics in the market.

"We expect Pfizer's CP-690550, which is in Phase III of development, to steal patient share from the
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes
2. Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
3. Sodium channel blocker shows promise as a potential treatment for cystic fibrosis
4. The future of personalized cancer treatment: An entirely new direction for RNAi delivery
5. An Aid to Tailoring Prostate Cancer Treatment
6. Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics
7. Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18
8. Mayo Clinic researchers say agent provides treatment option for women with hot flashes
9. Can New Surgery Revolutionize Diabetes Treatment?
10. Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment
11. New Cancer Treatment Achieves First Mesothelioma Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Adolescents, especially young males, who experiment with synthetic ... landing in emergency rooms across America. Recovery ... with a new treatment program for those addicted to ... the National Institute on Drug Abuse, synthetic marijuana has ... In 2012, 11 percent of high school seniors had ...
(Date:5/18/2013)... The California College of Ayurveda Spa is ... Ayurvedic Spa , the client receives stress relief therapies ... lifestyle recommendations and stress management techniques by a Clinical ... traditional healthcare system of India. It is based on ... basis for all optimum health. Ayurveda believes that where ...
(Date:5/18/2013)... Losing weight remains to be the biggest challenge ... new weight loss products available in the market today, Garcinia ... this newest weight loss supplement prove that dieting and exercising ... Cambogia is a sub-tropical fruit that is shaped like a ... suppress a person’s appetite, while it effectively burns fat at ...
(Date:5/18/2013)... 18, 2013 Scott Tischler of Tischler Brothers ... These five keys to losing weight played a huge part ... of Scott Tischler, Troy was able to lose a pound ... loss program should be approached with caution and any activity ... the five keys to weight loss that Scott Tischler advocates. ...
(Date:5/18/2013)... Wine World Accessories, a renowned online ... an attractive 25% discount on Franmara Dynamo Electric ... now purchase this electric corkscrew opener for $44.95 via ... The online store ensures delivery of their items within ... , A spokesperson from the online store elaborates ...
Breaking Medicine News(10 mins):Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2
... gymnasts are developing a wide variety of arm, wrist ... previously described gymnastic-related trauma, according to a study presented ... of North America (RSNA). , "The broad constellation of ... new going on in gymnastics training that is affecting ...
... EXCLUSIVE LAUNCH EVENT TODAY AT RED.MSN.COM , , ... , , PREMIER ISSUE DEBUTS WEDNESDAY, DECEMBER ... 1 Today, World AIDS Day , many of the greatest ... of (RED)WIRE, the innovative new music service from (RED). Throughout the day, ...
... exposed are your eyes,to harmful UV rays? Are you aware ... next eye appointment? Do you know where the closest eyecare,professional ... about eye health from the comfort of your home by ... Over 56 percent of Hispanics in the United States use ...
... Medical Inc., a leading manufacturer of breast MRI coils ... announcing an OEM Distribution Agreement for Sentinelle,s Vanguard(R) T-Series ... (RSNA) annual meeting in Chicago, Nov. 30 - Dec. ... Under this agreement, Toshiba will offer the Sentinelle ...
... is linked to hardening of the arteries , , SUNDAY, Nov. ... was brought on by last summer,s spike in gas prices ... automobile emissions are among a long list of risk factors ... coherent and consistent body of data that links particulate air ...
... 29 FUJIFILM Medical Systems USA is,pleased to announce ... acquired 100 percent of the Empiric stock, making the ... significant step,in Fujifilm,s growth strategy, and a demonstration of ... and health information technology. , ...
Cached Medicine News:Health News:MRI shows new types of injuries in young gymnasts 2Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 2Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 3Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 4Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 5Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 6Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 7Health News:Prevention and Eyecare Begin at Home 2Health News:Sentinelle Medical Enters OEM Distribution Agreement with Toshiba 2Health News:Heavy Traffic Can Be Heartbreaking 2Health News:Heavy Traffic Can Be Heartbreaking 3Health News:Fujifilm Acquires Information Systems Vendor Empiric 2Health News:Fujifilm Acquires Information Systems Vendor Empiric 3
(Date:5/16/2013)... Calif. , May 16, 2013 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies for ... Richard King , President and CEO, will ... at the Sheraton New York Hotel in New ... May 22, 2013 at 9:30 a.m. ET/6:30 a.m. PT. ...
(Date:5/16/2013)... , May 16, 2013  ULURU Inc. (OTCQB: ULUR) ... March 31, 2013 and provided a review of its operating ... Company is confirming the previously communicated outlook for 2013: ... , Expanding the network of distribution partners to cover all ... , Positioning Altrazeal ® to be marketed in approximately ...
(Date:5/16/2013)... , May 16, 2013  A new survey of ... with vulvar and vaginal atrophy (VVA) are either unaware ... are simply dissatisfied with the therapies available. The REVIVE ... VI ews of Treatment Options for Menopausal Vulvar/ ... the treatment of VVA, including lack of knowledge, reluctance ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 3
... Dec. 16 Cohera Medical Inc. today announced the ... its lead surgical adhesive product, TissuGlu®. Initiation of the ... of the lead product toward clinical practice. , ... to investigate the safety of TissuGlu and its effect ...
... , , HARTFORD, Conn., ... leading provider of home health benefits management services, announced ... from URAC, a Washington, DC-based health care accrediting organization ... URAC standards guarantee that only appropriately trained, qualified clinical ...
Cached Medicine Technology:First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3CareCentrix Receives URAC Health Utilization Management Accreditation 2
... unassayed control is intended as ... and automated assay methods used ... in human urine samples. This ... no reconstitution. This control is ...
... is the ultimate in convenience for urinalysis ... controls. DipandSpin is a combination product for ... new feature is the addition of creatinine ... measurements as well as for all analytes; ...
... are available in five protein concentrations: 12.5, ... are packaged in 30 mL dropper bottles. ... or dilution and are formulated in an ... human globulin at a ratio of 70% ...
... control is intended as a means ... methods. A new feature is the ... It is compatible with most major ... Access, Dimension, Elecsys, Stratus and Synchron. ...
Medicine Products: